Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumorsHui-Rong Jiang, David E Gilham, Kate Mulryan, et al.Osteoarthritis and Cartilage|January 11, 2005
Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytesSimon R Tew, Ying Li, Peraphan Pothacharoen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cellsEleanor J Cheadle, Robert E Hawkins, Hayley Batha, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2002
Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3zeta-based chimeric immune receptorsDavid E Gilham, Allison O'Neil, Chris Hughes, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2010
Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T cellsEleanor J Cheadle, Robert E Hawkins, Hayley Batha, et al.Tissue Engineering|May 29, 2004
Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9Ying Li, Simon R Tew, Amanda M Russell, et al.Expert Opinion on Biological Therapy|October 20, 2010
T regulatory cells in cancer: recent advances and therapeutic potentialEyad Elkord, Erik M Alcantar-Orozco, Simon J Dovedi, et al.Cancer Immunology, Immunotherapy : CII|May 10, 2007
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survivalRichard W Griffiths, Eyad Elkord, David E Gilham, et al.Cancer Immunology, Immunotherapy : CII|July 25, 2018
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cellsGemma L Owens, Marcus J Price, Eleanor J Cheadle, et al.International Journal of Cancer|August 10, 2004
Use of adenoviruses encoding CD40L or IL-2 against B cell lymphomaEl Kahina Meziane, Tapan Bhattacharyya, Anne C Armstrong, et al.Pageof 8